Safety and Immunogenicity of Two Doses of aH5N1 Vaccine in Adult and Elderly Subjects With and Without Underlying Medical Conditions

NCT02091908 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

540

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza, Human

Interventions

BIOLOGICAL: Novartis Investigational H5N1 vaccine
BIOLOGICAL: Novartis Investigational H5N1 vaccine
BIOLOGICAL: Novartis Seasonal Influenza Vaccine
BIOLOGICAL: Novartis Seasonal Influenza Vaccine

Sponsor

Seqirus

Collaborators

[object Object]